Reddy vs JBC
Pittsburgh associate professor Raju Reddy and a colleague sued JBC over a retraction. The case has been settled in January 2021, the baddies won and the precedent is set.
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Pittsburgh associate professor Raju Reddy and a colleague sued JBC over a retraction. The case has been settled in January 2021, the baddies won and the precedent is set.
Catherine Verfaillie is a zombie scientist: her past stem cell research long discredited, but she still is an influential and very well funded star of Belgian science. Now Elisabeth Bik had a fresh new look at Verfaillie’s papers
Elisabeth Bik reported 4 years ago 11 falsified papers by University of Nebraska oncologists. One was retracted, two corrected, the rest ignored.
Brain cancer professor Jasti Rao enjoyed the American dream of gigantic salary, political support and lavish research grants, in Texas and in Illinois. Did he ever perform any research, in-between casino gambling and terrorizing his lab employees? 109 fraudulent papers on PubPeer suggest otherwise.
Smut Clyde complained of his eyes hurting from all these repetitive patterns in neuron recordings. He now recovered, and wrote this report, about rat torturers of Michigan.
In 2018, the pharma giant Sanofi appointed with John Reed a new R&D head. Apparently Sanofi does not believe in PubPeer.
Oncotarget, the somewhat controversial OA journal, switched from pretend-soliciting my services to threatening to sue me for defamation. Their lawyer writes my disrespect caused them financial damage.
Gary Stacey is soybean researcher at University of Missouri and ASPB member. Whatever problems you might have with his science, the university already attested him a “clean bill of health”. Get a life.
This guest post by Elisabeth Bik will conclude the Fraud Triptych started by Smut Clyde. We shall meet a former mentee of Paul B Fisher, Sujit Bhutia, who is now busy fabricating data at his own lab at National Institute of Technology in India. Our next encounter will be with Fisher’s and Benjamin Bonavida’s past collaborator Devasis Chatterjee, who recently abruptly stopped being a principal investigator at the Brown University.
The new ERC President Mauro Ferrari used to closely collaborate with two very controversial cancer researchers at MD Anderson in Texas: Anil Sood and Gabriel Lopez-Beerestein. Will that experience affect ERC’s already wanting stance on research integrity?









